Literature DB >> 32223302

Human intestinal enteroids as a model of Clostridioides difficile-induced enteritis.

Melinda A Engevik1,2, Heather A Danhof3,4, Alexandra L Chang-Graham4, Jennifer K Spinler1,2, Kristen A Engevik3,4, Beatrice Herrmann1,2, Bradley T Endres5, Kevin W Garey5, Joseph M Hyser1,2, Robert A Britton3,4, James Versalovic1,2.   

Abstract

Clostridioides difficile is an important nosocomial pathogen that produces toxins to cause life-threatening diarrhea and colitis. Toxins bind to epithelial receptors and promote the collapse of the actin cytoskeleton. C. difficile toxin activity is commonly studied in cancer-derived and immortalized cell lines. However, the biological relevance of these models is limited. Moreover, no model is available for examining C. difficile-induced enteritis, an understudied health problem. We hypothesized that human intestinal enteroids (HIEs) express toxin receptors and provide a new model to dissect C. difficile cytotoxicity in the small intestine. We generated biopsy-derived jejunal HIE and Vero cells, which stably express LifeAct-Ruby, a fluorescent label of F-actin, to monitor actin cytoskeleton rearrangement by live-cell microscopy. Imaging analysis revealed that toxins from pathogenic C. difficile strains elicited cell rounding in a strain-dependent manner, and HIEs were tenfold more sensitive to toxin A (TcdA) than toxin B (TcdB). By quantitative PCR, we paradoxically found that HIEs expressed greater quantities of toxin receptor mRNA and yet exhibited decreased sensitivity to toxins when compared with traditionally used cell lines. We reasoned that these differences may be explained by components, such as mucins, that are present in HIEs cultures, that are absent in immortalized cell lines. Addition of human-derived mucin 2 (MUC2) to Vero cells delayed cell rounding, indicating that mucus serves as a barrier to toxin-receptor binding. This work highlights that investigation of C. difficile infection in that HIEs can provide important insights into the intricate interactions between toxins and the human intestinal epithelium.NEW & NOTEWORTHY In this article, we developed a novel model of Clostridioides difficile-induced enteritis using jejunal-derived human intestinal enteroids (HIEs) transduced with fluorescently tagged F-actin. Using live-imaging, we identified that jejunal HIEs express high levels of TcdA and CDT receptors, are more sensitive to TcdA than TcdB, and secrete mucus, which delays toxin-epithelial interactions. This work also optimizes optically clear C. difficile-conditioned media suitable for live-cell imaging.

Entities:  

Keywords:  Clostridioides difficile; actin; cell rounding; enteritis; enteroids; goblet cells; inflammatory bowel disease (IBD); live imaging; mucin 2; mucus; organoids; toxins

Mesh:

Substances:

Year:  2020        PMID: 32223302      PMCID: PMC7272722          DOI: 10.1152/ajpgi.00045.2020

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  159 in total

Review 1.  Barrier properties of mucus.

Authors:  Richard A Cone
Journal:  Adv Drug Deliv Rev       Date:  2008-12-16       Impact factor: 15.470

2.  Fatal Clostridium difficile enteritis after total abdominal colectomy.

Authors:  H F Yee; R S Brown; J W Ostroff
Journal:  J Clin Gastroenterol       Date:  1996-01       Impact factor: 3.062

3.  Persistence and toxin production by Clostridium difficile within human intestinal organoids result in disruption of epithelial paracellular barrier function.

Authors:  Jhansi L Leslie; Sha Huang; Judith S Opp; Melinda S Nagy; Masayuki Kobayashi; Vincent B Young; Jason R Spence
Journal:  Infect Immun       Date:  2014-10-13       Impact factor: 3.441

4.  A human antibody binds to alpha-galactose receptors and mimics the effects of Clostridium difficile toxin A in rat colon.

Authors:  C Pothoulakis; U Galili; I Castagliuolo; C P Kelly; S Nikulasson; P K Dudeja; T A Brasitus; J T LaMont
Journal:  Gastroenterology       Date:  1996-06       Impact factor: 22.682

5.  Interaction of the Clostridium difficile Binary Toxin CDT and Its Host Cell Receptor, Lipolysis-stimulated Lipoprotein Receptor (LSR).

Authors:  Sarah Hemmasi; Bernd A Czulkies; Björn Schorch; Antonia Veit; Klaus Aktories; Panagiotis Papatheodorou
Journal:  J Biol Chem       Date:  2015-04-16       Impact factor: 5.157

Review 6.  Clostridium difficile toxins: more than mere inhibitors of Rho proteins.

Authors:  Harald Genth; Stefanie C Dreger; Johannes Huelsenbeck; Ingo Just
Journal:  Int J Biochem Cell Biol       Date:  2008-01-05       Impact factor: 5.085

7.  Antibiotic-associated pseudomembranous enteritis due to Clostridium difficile.

Authors:  B Tsutaoka; J Hansen; D Johnson; M Holodniy
Journal:  Clin Infect Dis       Date:  1994-06       Impact factor: 9.079

8.  Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain.

Authors:  M R Popoff; E J Rubin; D M Gill; P Boquet
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

9.  Chemical and Stress Resistances of Clostridium difficile Spores and Vegetative Cells.

Authors:  Adrianne N Edwards; Samiha T Karim; Ricardo A Pascual; Lina M Jowhar; Sarah E Anderson; Shonna M McBride
Journal:  Front Microbiol       Date:  2016-10-26       Impact factor: 5.640

Review 10.  Human Enteroids/Colonoids and Intestinal Organoids Functionally Recapitulate Normal Intestinal Physiology and Pathophysiology.

Authors:  Nicholas C Zachos; Olga Kovbasnjuk; Jennifer Foulke-Abel; Julie In; Sarah E Blutt; Hugo R de Jonge; Mary K Estes; Mark Donowitz
Journal:  J Biol Chem       Date:  2015-12-16       Impact factor: 5.486

View more
  7 in total

Review 1.  Patient-derived organoids for therapy personalization in inflammatory bowel diseases.

Authors:  Marianna Lucafò; Antonella Muzzo; Martina Marcuzzi; Lorenzo Giorio; Giuliana Decorti; Gabriele Stocco
Journal:  World J Gastroenterol       Date:  2022-06-28       Impact factor: 5.374

2.  Bacteroides ovatus Promotes IL-22 Production and Reduces Trinitrobenzene Sulfonic Acid-Driven Colonic Inflammation.

Authors:  Faith D Ihekweazu; Melinda A Engevik; Wenly Ruan; Zhongcheng Shi; Robert Fultz; Kristen A Engevik; Alexandra L Chang-Graham; Jasmin Freeborn; Evelyn S Park; Susan Venable; Thomas D Horvath; Sigmund J Haidacher; Anthony M Haag; Annie Goodwin; Deborah A Schady; Joseph M Hyser; Jennifer K Spinler; Yuying Liu; James Versalovic
Journal:  Am J Pathol       Date:  2021-01-28       Impact factor: 4.307

Review 3.  From the Dish to the Real World: Modeling Interactions between the Gut and Microorganisms in Gut Organoids by Tailoring the Gut Milieu.

Authors:  Na-Young Park; Ara Koh
Journal:  Int J Stem Cells       Date:  2022-02-28       Impact factor: 2.500

4.  Investigation of metabolic crosstalk between host and pathogenic Clostridioides difficile via multiomics approaches.

Authors:  Ji-Eun Kwon; Sung-Hyun Jo; Won-Suk Song; Jae-Seung Lee; Hyo-Jin Jeon; Ji-Hyeon Park; Ye-Rim Kim; Ji-Hyun Baek; Min-Gyu Kim; Seo-Young Kwon; Jae-Seok Kim; Yung-Hun Yang; Yun-Gon Kim
Journal:  Front Bioeng Biotechnol       Date:  2022-09-02

5.  Reuterin disrupts Clostridioides difficile metabolism and pathogenicity through reactive oxygen species generation.

Authors:  Melinda A Engevik; Heather A Danhof; Ritu Shrestha; Alexandra L Chang-Graham; Joseph M Hyser; Anthony M Haag; Mahmoud A Mohammad; Robert A Britton; James Versalovic; Joseph A Sorg; Jennifer K Spinler
Journal:  Gut Microbes       Date:  2020-11-09

Review 6.  Research in a time of enteroids and organoids: how the human gut model has transformed the study of enteric bacterial pathogens.

Authors:  Sridevi Ranganathan; Emily M Smith; Jennifer D Foulke-Abel; Eileen M Barry
Journal:  Gut Microbes       Date:  2020-11-09

7.  Human-Derived Bifidobacterium dentium Modulates the Mammalian Serotonergic System and Gut-Brain Axis.

Authors:  Melinda A Engevik; Berkley Luck; Chonnikant Visuthranukul; Faith D Ihekweazu; Amy C Engevik; Zhongcheng Shi; Heather A Danhof; Alexandra L Chang-Graham; Anne Hall; Bradley T Endres; Sigmund J Haidacher; Thomas D Horvath; Anthony M Haag; Sridevi Devaraj; Kevin W Garey; Robert A Britton; Joseph M Hyser; Noah F Shroyer; James Versalovic
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2020-08-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.